| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 117,1 k € | -20.5% | 147,4 k € | -10.8% | 165,2 k € | +39.5% | 118,4 k € | +36.1% | 87,0 k € | +8.6% | 80,2 k € | -35.6% | 124,5 k € | -13.3% | 143,6 k € | +3.8% | 138,3 k € | -13.6% | 160,0 k € | +12.5% | 142,3 k € | +0.5% | 141,6 k € | -3.5% | 146,8 k € | -14.5% | 171,6 k € | -3.2% | 177,2 k € | +8.6% | 163,2 k € | +40.9% | 115,8 k € | +147.1% | 46,9 k € | -5.4% | 49,5 k € | |
| EBITDA | 116,0 k € | -20.7% | 146,3 k € | -11.3% | 164,9 k € | +40.5% | 117,3 k € | +36.7% | 85,9 k € | +8.6% | 79,1 k € | -35.9% | 123,4 k € | -13.0% | 141,9 k € | +3.2% | 137,5 k € | -13.5% | 159,0 k € | +12.4% | 141,5 k € | +0.8% | 140,4 k € | -4.0% | 146,1 k € | -14.5% | 170,9 k € | -3.2% | 176,6 k € | +8.6% | 162,5 k € | +41.5% | 114,9 k € | +149.0% | 46,1 k € | -5.4% | 48,8 k € | |
| Operating profit | 82,5 k € | -27.2% | 113,3 k € | -18.2% | 138,5 k € | +34.9% | 102,7 k € | +47.1% | 69,8 k € | +5.8% | 66,0 k € | -41.5% | 112,8 k € | -14.1% | 131,3 k € | +3.5% | 126,9 k € | -14.8% | 149,0 k € | +13.0% | 131,9 k € | +1.0% | 130,5 k € | -5.3% | 137,8 k € | -15.3% | 162,6 k € | -3.0% | 167,6 k € | +9.7% | 152,9 k € | +44.6% | 105,7 k € | +158.1% | 41,0 k € | -8.0% | 44,5 k € | |
| Profit/loss | 55,7 k € | -27.3% | 76,6 k € | -18.3% | 93,7 k € | +32.5% | 70,7 k € | +47.1% | 48,1 k € | +4.5% | 46,0 k € | -42.2% | 79,6 k € | -2.2% | 81,4 k € | +3.8% | 78,4 k € | -20.2% | 98,2 k € | +12.6% | 87,2 k € | -7.1% | 93,9 k € | +2.1% | 92,0 k € | -14.0% | 107,0 k € | -3.2% | 110,6 k € | +10.3% | 100,2 k € | +43.4% | 69,9 k € | +167.0% | 26,2 k € | -10.3% | 29,2 k € | |
| Equity | 428,2 k € | +2.3% | 418,5 k € | -0.7% | 421,5 k € | +3.0% | 409,2 k € | -1.9% | 417,0 k € | +13.0% | 368,9 k € | +14.2% | 322,9 k € | +32.7% | 243,3 k € | +50.3% | 161,9 k € | +93.9% | 83,5 k € | +10.9% | 75,2 k € | +3.0% | 73,0 k € | +5.7% | 69,1 k € | +3.0% | 67,1 k € | +11.7% | 60,1 k € | +21.3% | 49,5 k € | +26.0% | 39,3 k € | +33.7% | 29,4 k € | +4.2% | 28,2 k € | |
| Total assets | 956,5 k € | -8.1% | 1,0 M € | -5.3% | 1,1 M € | +6.9% | 1,0 M € | +66.2% | 619,2 k € | +28.0% | 483,7 k € | +46.9% | 329,3 k € | +30.2% | 252,9 k € | +48.0% | 170,8 k € | -7.9% | 185,6 k € | +3.7% | 179,0 k € | -11.2% | 201,5 k € | +0.5% | 200,5 k € | -1.8% | 204,2 k € | -0.4% | 205,0 k € | +18.0% | 173,8 k € | +14.2% | 152,1 k € | +101.1% | 75,7 k € | -19.2% | 93,6 k € | |
| Cash | 151,7 k € | -30.4% | 218,2 k € | -9.7% | 241,6 k € | -25.6% | 324,6 k € | +25.5% | 258,8 k € | +22.9% | 210,5 k € | +83.5% | 114,7 k € | -39.7% | 190,2 k € | +45.6% | 130,7 k € | -4.3% | 136,5 k € | +13.6% | 120,2 k € | -7.9% | 130,5 k € | -29.2% | 184,5 k € | +0.7% | 183,2 k € | +20.8% | 151,7 k € | +6.9% | 141,9 k € | +47.3% | 96,3 k € | +55.6% | 61,9 k € | -11.3% | 69,8 k € | |
| Debts | 528,4 k € | -15.1% | 622,5 k € | -8.2% | 677,9 k € | +9.4% | 619,7 k € | +206.4% | 202,2 k € | +77.1% | 114,2 k € | +1885.8% | 5,7 k € | -35.9% | 9,0 k € | +0.6% | 8,9 k € | -91.3% | 102,1 k € | -1.6% | 103,7 k € | -19.3% | 128,5 k € | -2.2% | 131,4 k € | -4.1% | 137,1 k € | -5.4% | 145,0 k € | +16.6% | 124,3 k € | +10.1% | 112,9 k € | +143.9% | 46,3 k € | -29.2% | 65,4 k € | |
Private limited company · Overijse · incorporated on 16/06/2004
Private limited company profitable and well capitalised. Cash position declining (-30.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Pascale Deryckere is a Private limited company incorporated in 2004. Its main activity is: Specialist medical practice activities. Its registered office is in Overijse.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.